Detection of SARS-CoV-2 RNA in the Serum Samples of Healthy Blood Donors

dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.contributor.authorDalgic, Bahise Cagla Taskin
dc.contributor.authorYenisehirli, Gulgun
dc.contributor.authorTanriverdi, Elif Seren
dc.contributor.authorAlici, Ayse
dc.contributor.authorOtlu, Baris
dc.date.accessioned2024-08-04T20:10:22Z
dc.date.available2024-08-04T20:10:22Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIntroduction: The transmission rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by blood transfusion is thought to be low; however, it has not yet been proven whether the virus is transmitted by blood transfusion. Published studies have reported that SARS-CoV-2 RNA has been detected in the blood, plasma, or serum of infected individuals. This study aimed to investigate the presence of SARS-CoV-2 RNA in the serum of blood donors and evaluate the risk of transmission of SARS-CoV-2 by transfusion. Materials and Methods: In this study, 200 blood samples were taken from volunteer blood donors. In all serum samples, SARS-CoV-2 RNA was detected by reverse-transcription quantitative polymerase chain reaction assay. Medical records of the donors and recipients were retrospectively reviewed. Results: SARS-CoV-2 RNA was detected in seven (3.5%) of the donor serum samples. None of the positive donors had symptoms of coronavirus disease 2019 (COVID-19), and none had been admitted to the hospital after donation. Seven SARS-CoV-2 RNA-positive donor blood components were given to 12 recipients. No medical records indicated that COVID-19 occurred after the transfusion of blood components for recipients. Conclusion: This study demonstrated the presence of SARS-CoV-2 RNA in the serum of asymptomatic donors. Although our data suggest that the transfusion of blood products from asymptomatic donors to recipients with SARS-CoV-2 RNA in their serum may not result in COVID-19, further studies are needed to prove that SARS-CoV-2 is not transmitted by blood transfusion.en_US
dc.identifier.doi10.4274/mjima.galenos.2023.2022.4
dc.identifier.issn2147-673X
dc.identifier.scopus2-s2.0-85168588728en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.trdizinid1164136en_US
dc.identifier.urihttps://doi.org/10.4274/mjima.galenos.2023.2022.4
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1164136
dc.identifier.urihttps://hdl.handle.net/11616/92741
dc.identifier.volume12en_US
dc.identifier.wosWOS:000967478500001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofMediterranean Journal of Infection Microbes and Antimicrobialsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSARS-CoV-2 RNAen_US
dc.subjectblood donoren_US
dc.subjecttransfusionen_US
dc.titleDetection of SARS-CoV-2 RNA in the Serum Samples of Healthy Blood Donorsen_US
dc.typeArticleen_US

Dosyalar